Clinical Trial Update: LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether adding low-molecular-weight heparin to low-dose aspirin improves prevention of preeclampsia in high-risk pregnant patients; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Hypertension
• Preeclampsia

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• Low-dose aspirin (acetylsalicylic acid)

Snippet

Sponsor: Alexandra Hospital, Athens, Greece | Conditions: Preeclampsia Severe, Toxemia Of Pregnancy | Phase 4 | Status: RECRUITING